XML 47 R34.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders’ Equity (Tables)
 12 Months Ended
Dec. 31, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Summary of Option Activity

A summary of options activity under the Company’s stock option plan for the years ended December 31, 2025 and 2024 are presented below:

   

  

Number of

Shares

  

Weighted

Average

Exercise

Price

  

Total

Intrinsic

Value

  

Weighted

Average

Remaining

Contractual Life (in years)

 
Options outstanding as of December 31, 2024   1,302,500   $1.96   $804,300    1.7 
Employee options granted   1,918,053    2.84    4,500    6.3 
Employee options exercised   (1,100,000)   1.90    -    - 
Employee options expired   (68,158)   2.47    -    - 
Employee options forfeited   (50,000)   1.40    -    - 
Options outstanding as of December 31, 2025   2,002,395   $2.84   $460,715    5.6 
Options vested and exercisable as of December 31, 2025   1,338,910   $2.52   $298,490    5.8 

 

Option exercises during fiscal year 2025 primarily related to cashless exercises of vested options, and option forfeitures and expirations reflect unvested and vested awards, respectively, that were cancelled in connection with employee departures in the ordinary course of business.

 

  

Number of

Shares

  

Weighted

Average

Exercise

Price

  

Total

Intrinsic

Value

  

Weighted

Average

Remaining

Contractual

Life (in years)

 
Options outstanding as of December 31, 2023   1,200,000   $2.12   $8,700    2.4 
Employee options granted   120,000    1.52    -    4.6 
Employee options expired   (17,500)   10.30    -    - 
Options outstanding as of December 31, 2024   1,302,500   $1.96   $804,300    1.7 
Options vested and exercisable as of December 31, 2024   1,141,250   $2.02   $649,125    1.3 
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value

The fair value of market-based LTI RSUs is estimated using a Monte Carlo simulation. The following assumptions were used to determine fair value as of the January 1, 2023, modification date:

 

  

January 1, 2023

(Modification)

 
Vesting Hurdle Price  $3.81 - $30.52 
Term (years)   4.00 
Expected stock price volatility   97.30%
Risk-free rate of interest   4.10%
Schedule of Restricted Stock Units

     

 Market Cap Vesting Thresholds 
 

$ 100 million

    

$ 150 million

    

$ 300 million

 
 50,000    50,000    50,000 
Summary of Restricted Stock

The following table summarizes RSU activity under the 2021 Plan for the years ended December 31, 2025 and 2024:

 

  

Number of

Restricted

Stock Units

  

Weighted

Average Grant

Date Fair

Value

 
Nonvested as of December 31, 2023   1,606,373   $3.25 
Granted   300,000    1.71 
Vested   (445,350)   3.13 
Vested and converted to restricted common shares   (220,052)   2.01 
Forfeited   (100,000)   1.63 
Nonvested as of December 31, 2024   1,140,971   $3.27 
Granted   150,000    2.47 
Vested   -    - 
Vested and converted to restricted common shares   (1,170,834)   3.05 
Forfeited   (120,137)   4.37 
Nonvested as of December 31, 2025   -   $- 
Schedule of Stock-based Compensation Expense

Stock-based compensation expenses are recorded as a part of general and administrative expenses, compensation expenses and cost of revenues. Stock-based compensation expenses for the years ended December 31, 2025 and 2024 were as follows:

   2025   2024 
   For the Year Ended December 31, 
   2025   2024 
Employee stock option awards  $605,070   $2,973,503 
Employee restricted stock awards   451,840    1,188,963 
Forfeiture of employee restricted stock unit and share awards   (549,840)   - 
Employee share-based salary payments    -    1,176,679 
Non-employee restricted stock awards   150,006    165,011 
Total stock-based compensation  $657,076   $5,504,156 
Summary of Warrant Activity

The following is a summary of warrant activity for the years ended December 31, 2025 and 2024:

    

  

Number of

Warrants

 
Outstanding as of December 31, 2023   712,500 
Expiration of warrants   -
Outstanding as of December 31, 2024   712,500 
Issuance of warrants in connection with convertible note   2,781,291 
Exercised   (1,369,725)
Outstanding as of December 31, 2025   2,124,066 
Common Stock [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Summary of Restricted Stock

The following table summarizes restricted Common Stock activity under the 2021 Plan for the years ended December 31, 2025 and 2024:

  

Number of

Restricted Shares

of Common Stock

 
Outstanding and nonvested as of December 31, 2023   - 
Converted from restricted stock units   258,294 
Granted   12,500 
Outstanding and nonvested as of December 31, 2024   270,794 
Converted from restricted stock units   1,170,834 
Vested   (500,593)
Forfeited   (462,660)
Outstanding and nonvested as of December 31, 2025   478,375 
Restricted Stock [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value

  

   January 1, 2025 
Vesting Hurdle Price  $5.26 - $15.79 
Term (years)   2.00 
Expected stock price volatility   92.70%
Risk-free rate of interest   4.25%
2021 Equity Incentive Plan [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Schedule of Weighted-Average Assumptions Used to Estimate Fair Value

The following weighted-average assumptions were used to estimate the fair value of options granted during the years ended December 31, 2025 and 2024, using the Black-Scholes model:

   

  

For the Year Ended December 31,

 
   2025   2024 
Exercise price  $2.79   $1.52 
Term (years)   6.65    5.00 
Expected stock price volatility   115.79%   141.86%
Risk-free rate of interest   4.08%   4.50%